Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits

BACKGROUND: Opioids are not recommended for routine treatment of migraine because their benefits are outweighed by risks of medication overuse headache and abuse/dependence. A March 2016 US Food and Drug Administration (FDA) safety communication warned of the risk of serotonin syndrome from using op...

Descripción completa

Detalles Bibliográficos
Autores principales: Molina, Kyle C, Fairman, Kathleen A, Sclar, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937481/
https://www.ncbi.nlm.nih.gov/pubmed/29760569
http://dx.doi.org/10.2147/DHPS.S151073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5937481/
https://www.ncbi.nlm.nih.gov/pubmed/29760569
http://dx.doi.org/10.2147/DHPS.S151073

Ejemplares similares